Raymond C. Jordan joined Amgen as senior vice president, Corporate Affairs, in October 2012. In this role, Jordan is responsible for strategic communications across Amgen, including internal and external communications, issues management, and philanthropy.   Prior to joining Amgen, Jordan served as vice president of Public Affairs and Corporate Communication for Johnson & Johnson. He joined the company in 2003 as vice president, Group Communications, where he was focused on strategic communications for the Medical Devices and Diagnostics Group until he was appointed chief communication officer in 2004, ultimately overseeing the public affairs and corporate communications for more than 250 operating companies in 60 countries. Prior to Johnson & Johnson, Jordan was vice president of Communications and Information for Pfizer, where he held a range of positions over the course of 17 years. Earlier in his career, he was a reporter for a regional daily newspaper, held positions with Bristol-Myers and Dun & Bradstreet, and was cofounder of a management consulting firm.   Throughout the years, Jordan has also served the industry as chair of PhRMA’s Public Affairs section and the National Pharmaceutical Council’s User Group, and he has served as a member of the board of directors of the Foundation for American Communications, the board of trustees of the Institute for Public Relations, and the Seminar Committee, as well as a board member of the Arthur W. Page Society.   He is a graduate of Yale University and earned an MBA in marketing and finance from Columbia University.

 Nephrology